Quarterly Activities/Appendix 5B Cash Flow Report
Released
Released
Announcement PDF
ASX Announcement
28 JANUARY 2022
DECEMBER 2021 – QUARTERLY REPORT
Highlights
PARKWAY PROCESS SOLUTIONS (PPS)
§
Product Development
§
§
§
Progressed the development of a range of high-performance, rapidly deployable
integrated water treatment plants based on a modular and reconfigurable design.
Business Development
§
Continued to successfully secure new business from a diverse range of companies, for
the provision of industrial water treatment related products, services, and solutions.
§
Awarded another contract to perform an early-stage preliminary engineering study for
a wastewater treatment plant contemplated by a government entity.
§
Implementation of Integrated Management System is supporting business
development, by assisting in the establishment of Parkway as an approved vendor.
Group Sales: increased to approximately $1 million, with cash receipts increasing to $0.87
million, a 175% increase from the prior quarter, underpinned by rapidly growing sales pipeline.
PARKWAY PROCESS TECHNOLOGIES (PPT)
§
Continued progress in leveraging proprietary process technology platform to support existing
and emerging business development initiatives.
§
Core Technologies
§
Construction of new scaled-up iBC® pilot plant on-track to commence in February 2022.
§
Technoeconomic evaluations and collaboration, supporting aMES® commercialisation.
§
Third-Party Technologies: secured access to an innovative membrane-based technology.
§
Commercialisation Activities: include ongoing technoeconomic evaluations to demonstrate the
substantial operational, financial and sustainability advantages of the technology portfolio.
PARKWAY VENTURES (PV)
§
The KLPP-Joint Venture granted 3 new exploration licences, covering KLPP project area.
CORPORATE
§
Strong balance sheet with $4.9 million in cash reserves as at 31 December 2021.
§
Cash balance excludes grant funds and $0.25 million R&D tax incentive rebate for FY21.
Parkway Corporate Limited (“Parkway” or the “Company”) (ASX: PWN) is pleased to report its activities
for the quarter ending 31 December 2021. This report is presented by operating division (strategic
busines unit), as follows:
§
Parkway Process Solutions (PPS)
§
Parkway Process Technologies (PPT)
§
Parkway Ventures (PV)
§
Corporate (Parkway group)
PARKWAY PROCESS SOLUTIONS (PPS)
Parkway Process Solutions (Parkway Process Solutions Pty Ltd, PPS) is a wholly owned subsidiary
and the main operating division of the Company.
Business & Corporate Development
Growth of PPS
Underpinned by several strategic initiatives1, the Company continues to build and expand PPS, in order
to capture commercial opportunities relating to industrial water treatment, initially in Australia. In addition
to generating growing revenues through the provision of conventional water treatment solutions, PPS
is also increasingly supporting the commercialisation of the Company’s next-generation technology
portfolio, including the delivery of highly differentiated integrated water treatment and industrial process
solutions.
Business Development
During the reporting period, PPS continued to successfully secure new business from a range of
companies, for the provision of industrial water treatment related products, services, and solutions, in
line with the stated objectives of establishing PPS. PPS is also developing a range of modular water
treatment plants (see below), which will further support ongoing busines development efforts.
Encouragingly, PPS achieved first orders from a range of new customers, involving the provision of
new products and services, including the sale of a chemical dosing system to an engineering company,
which represents the first international sale of a packaged system, by PPS.
Subsequent to the reporting period, the Company was also awarded a contract from a government
entity, to perform an early-stage preliminary engineering study for a wastewater treatment plant (further
details provided in the Activities Subsequent to Reporting Period, section of this report).
The Company expects the recent implementation of an Integrated Management System (further details
provided in the Corporate – Integrated Management System, section of this report) and corresponding
certification, will further support the establishment of PPS as a qualified vendor, and assist in a range
of business development related initiatives. With a growing inhouse engineering and technical services
team, an innovative product and services offering and operations in Perth, Melbourne and Darwin, PPS
is well placed to secure larger industrial water related opportunities moving forward.
Additional business development opportunities including collaborations with several previously
foreshadowed companies, continues to progress positively, with a range of collaborative arrangements
agreed with several parties. In order to assist in managing the growing portfolio of business
opportunities and support ongoing business development, PPS has recently recruited an experienced
business development manager.
1
The Company announced the preliminary launch of PPS on 08 July 2021, as well as the completion of the acquisition of two water businesses,
Multi-Wet on 26 February 2021 and Mawpump on 03 September 2021.
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
2
Product Development
Through the Australia-wide operations of PPS (incorporating acquired operations), Parkway has
identified several opportunities for relatively small, rapidly deployable, integrated water treatment plants
based on a modular and reconfigurable design platform. Parkway has progressed the design of a range
of these modular water treatment systems, and has taken delivery of most components, including longlead items, which will also become stocked items. Parkway has received very favourable feedback
regarding the advantages of the proposed modular systems, including the pre-sale PPS design
capabilities, and the post-sale support (service and consumables), which is becoming increasingly
important, given the significant supply chain challenges being experienced, globally.
Importantly, the growing inhouse product development capability, will also assist Parkway in designing,
building and delivering modular water treatment (and related process) plants, incorporating
technologies being commercialised by Parkway Process Technologies.
Corporate Development
PPS continues to successfully secure access, including distributorships to high-value and specialty
industrial water treatment related products, from a range of leading global OEMs with additional
negotiations ongoing. Whilst these products represent attractive business opportunities (for either
resale or as part of a value-added conventional water treatment solution), in many instances, these
products also support the development and provision of more innovative solutions incorporating PPT
technologies.
Quarterly Sales
As a result of ordinary operations, PPS generated group sales in the order of $1 million during the
quarter, with cash receipts from customers increasing to $0.87 million, a 175% increase from the prior
quarter. The increase in cash receipts incorporates the first full quarter contribution from the recently
acquired Mawpump business, however, given the normal ramp-up period associated with integrating
new business divisions, there is a timing impact on working capital, where cash receipts lag the
corresponding sales during the relevant period. Given the significant progress and corresponding
investments in PPS to date, the Company remains optimistic about building a sustainable and rapidly
growing revenue base moving forward.
PARKWAY PROCESS TECHNOLOGIES (PPT)
Parkway Process Technologies (Parkway Process Technologies Pty Ltd, PPT) continued to make
progress in leveraging its proprietary (core) process technology platform to support existing and
emerging business development initiatives. PPT also continues to make progress with a range of thirdparty process technologies, that enable Parkway to provide a broader range of synergistic industrial
process technologies.
Many of the developments outlined in the Parkway Process Solutions (PPS) – Business Development
& Corporate Development sections, are being pursued, as they also support the ongoing
commercialisation of the PPT technology portfolio.
Core Technologies – iBC®
The iBC® technology involves the pre-treatment of complex brines, particularly from the energy, mining
and other industrial sectors, to enable further downstream processing, to reduce wastewater volumes
and potentially recover a range of valuable chemical products.
The Company is exploring large-scale and high-value potential applications of the iBC® technology with
a range of industrial companies.
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
3
Ongoing testwork continues to provide encouragement that in addition to achieving significant
wastewater volume reductions, the application of the iBC® technology is likely to be able to achieve a
highly desirable zero-liquid discharge (ZLD) solution for certain applications. In addition to the
advantages of a ZLD approach, recent testwork continues to support the business case that an iBC®
based processing route, also has the potential to create a valuable revenue stream, through the sale of
industrial chemicals.
New iBC® Pilot Plant
Given the highly encouraging results from testwork performed throughout 2021, as well as positive
industry feedback, the Company has finalised the design for a scaled-up iBC® pilot plant, procured longlead items and is on-track to commence building the new pilot plant in February 2022. The new iBC®
pilot plant will assist the Company perform larger scale testwork and produce product samples, for
industry evaluation. The scaled-up iBC® pilot plant will also support a range of ongoing commercial
discussions with a range of prospective clients and partners.
Core Technologies – aMES®
The aMES® technology enables the processing of concentrated industrial process and wastewater
streams including brine solutions, to recover a range of valuable compounds, reagents, and fresh water.
In late 2020, the Company finalised the Karinga Lakes Potash Project – Pre-feasibility Study (KLPPPFS), which assisted the Company to demonstrate the significant advantages of the aMES®
technology. In conjunction with the PFS, a new state-of-the-art aMES® pilot plant was commissioned,
providing the Company with an important process demonstration, optimisation and validation capability,
an essential requirement for successful commercialisation of the aMES® technology. During the quarter,
several process design modifications were made to the aMES® pilot plant, to further enhance the
performance and validate the advantages of the technology.
The performance data generated by the aMES® pilot plant, is providing important information that will
impact the engineering design of a commercial-scale modularised aMES® plant. During the reporting
period, the Company continued to perform a range of technoeconomic evaluations as well as engage
in discussions with a range of parties, to determine a suitable pathway towards commercial
arrangements.
Core Technologies – Other
By leveraging the process engineering capabilities of the Company, PPT has been able to develop
innovative applications for a range of water treatment processes, to achieve improvements in the
processing and treatment of challenging industrial wastewater streams. In addition, the Company
continues to develop new technologies as well as identify additional applications for its portfolio of
proprietary process technologies, to solve high-value problems facing industry.
Third-Party Technologies – Various
As part of efforts to further expand the coverage of Parkway’s cutting-edge technology portfolio, the
Company is continually evaluating a range of potential technology platforms. The most attractive
technology platforms are those that not only provide substantial advantages over conventional
processes but are also highly complementary with Parkway’s existing technologies.
In this regard, following extensive technology evaluation, during the reporting period, Parkway entered
into a Strategic Partnership Agreement with a leading European membrane technology company. The
partnership agreement provides a collaboration framework, including a pathway for Parkway to design,
build and install water and wastewater treatment plants, based on this innovative membrane-based
technology. The innovative membrane-based technology provides Parkway with a highly effective and
selective pre-concentration technology, which enables more dilute feedstocks including brine and/or
wastewater to be concentrated, before treatment with Parkway’s aMES® process technology platform.
The collaboration between the parties incorporates a mechanism to securing exclusivity to the
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
4
technology including in key energy and mining related applications, subject to making continued
technical progress, predominantly based on application specific piloting. In order to assist with the rapid
screening of potential projects and enable efficient technology demonstration, Parkway has recently
taken delivery of a small, packaged pilot plant incorporating the innovative membrane-based
technology. Additional information about the pilot plant based on the innovative membrane-based
technology, is outlined in the Activities Subsequent to Reporting Period section of this report.
As part of PPS’s growing modular product development capabilities, the Company continues to invest
in developing capabilities to be able to build a modular system based on commercial scale equipment,
including incorporation of the innovative membrane-based technology.
Commercialisation Activities
Parkway continues to perform a range of evaluations to demonstrate the substantial operational,
financial and sustainability advantages of the technology portfolio, incorporating both the core and thirdparty technologies.
During the 2021 Annual General Meeting presentation, the Company foreshadowed its expectation of
being awarded a contract to perform a feasibility study by a major global company. The Company has
been subsequently advised the client has secured internal funding approval, with the parties working
collaboratively to finalise appropriate procurement and contractual arrangements. Parkway cautions
that although the discussions with the client are well progressed, there can be no certainty that the
feasibility study will proceed or that a term sheet or other binding agreement for the delivery of the
project will be entered into.
PARKWAY VENTURES (PV)
Parkway Ventures (Parkway Ventures Pty Ltd, PV) holds all resource project and royalty related
interests owned by the Company.
Karinga Lakes Potash Project (KLPP, 15% interest, earning 40%)
Parkway currently holds an equity interest in the Karinga Lakes Potash Project (KLPP), through
Parkway Ventures. As a result of a tenement rationalisation process, during the quarter, no substantive
mining exploration activities occurred in relation to this project.
The KLPP is a joint venture between Verdant Minerals Pty Ltd and Consolidated Potash Corporation
Pty Ltd (a wholly owned subsidiary of the Company), which is administered through Territory Potash
Pty Ltd (JV Operator).
On 05 Nov 2020, the Company announced completion of the KLPP-PFS, a pre-feasibility study based
on the strategic application of the aMES® technology. The Company notes the recent strength in
commodity markets, is supporting elevated fertiliser prices, with the primary target product from the
KLPP, sulphate of potash (SOP), trading significantly higher than the prices assumed by the Company
in the KLPP-PFS.
Following completion of planned near-term activities and finalisation of joint venture accounting, the
Company anticipates satisfying the earn-in requirements to have acquired a 40% working interest in
the project.
As previously announced, the JV Operator had applied to the Government of the Northern Territory of
Australia (NT Government) for three exploration licences (Exploration Licences) (to effectively replace
the original seven (7) exploration licences) covering a broadly equivalent exploration tenure to the preexisting project area. Following the recent dismissal of a Native Title Objection by the National Native
Title Tribunal (as announced on 14 October 2021), on 13 December 2021, Parkway announced that
the NT Government advised the grant the Exploration Licences had occurred, with an effective date of
30 November 2021, for an initial term expiring on 29 November 2027.
As at 31 December 2021, exploration tenure for the KLPP project area was held in the three newly
granted exploration licences, details of which are outlined in the Tenement Interests section of this
Quarterly Report, outlined below.
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
5
Mineral Resources
The Mineral Resource Estimate underpinning the KLPP-PFS is summarised below.
Lake
Mineralisation
Contained in Drainable
Porosity
Indicated Mineral
Resource contained in
Total Porosity that meets
reasonable prospects of
economic extraction
Potassium Tonnage
Potassium Tonnage
Potassium Tonnage
(kt)
(kt)
(kT)
580
430
Production
Lakes included in the mine plan (x8)
Sub Total
300
Remaining Lakes (x16)
Sub total
220
430
Totals
520
1000
430
The Mineral Resource estimate underpinning the production targets in this announcement were
prepared by a competent person in accordance with the requirements of the JORC Code 2012.
COMPETENT PERSONS STATEMENT
Parkway reported the Mineral Resource estimate for the Karinga Lakes Potash Project in accordance
with Listing Rule 5.8 in its ASX announcement dated 5 November 2020. Parkway confirms that it is not
aware of any new information or data that materially affects the information included in the
announcement of 5 November 2020 and that all material assumptions and technical parameters
underpinning the estimates in the announcement of 5 November 2020 continue to apply and have not
materially changed.
Other Resource Projects
During the quarter, the Company continued to consider potential involvement in a number of additional
resource projects, whereby the Company may contribute its proprietary process technologies, in
exchange for the Company receiving agreed equity interests and/or royalties in the respective project/s.
In the event the Company is successful in adopting this strategy, the Company intends to leverage its
technology portfolio to gain economic exposure to additional resources project/s (including, amongst
others, lithium brine projects), without necessarily incurring material balance sheet exposure. For the
avoidance of doubt, this technology commercialisation strategy is similar and consistent with the
previously disclosed innovative business model, being implemented by the Company.
CORPORATE
Integrated Management System
The Company is committed to achieving high quality environmental, social & governance (ESG)
outcomes, including achieving and maintaining high levels of corporate governance compliance. As
part of the Company’s commitment to industry best practices and continuous improvement, the
Company has recently developed an Integrated Management System, to facilitate the certification and
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
6
ongoing compliance in relation to:
§
ISO9001:2015, Quality Management System;
§
ISO14001:2015, Environmental Management System; and
§
ISO 45001:2018, Occupational Health & Safety Management System.
Based on an independent audit and site evaluation performed in January 2022, the Company
anticipates achieving certification for all the relevant standards, in the near term.
Funding
During the quarter, the Company continued to experience elevated cash outflows, largely as a result of
the establishment of Parkway Process Solutions, including the associated build-up of significant
inventory.
Notwithstanding the increased investment in establishing PPS, as at 31 December 2021, the Company
held cash reserves of $4.9 million. The strong cash position means the Company is well funded to
execute the CY2022 business plan, including the continued roll-out of PPS, to the point where it is
anticipated to make an increasingly significant revenue contribution to the group.
Grant Funds
The Company has a strong track-record in securing a range of grants, including from the Australian
Research Council (ARC), to support innovative research and development (R&D) and associated
commercialisation related activities. The Company has recently been invited to participate in several
research grant schemes designed to fund innovative research, which the Company intends to pursue,
where research interests align, and commercial arrangements are consistent the Company’s
requirements.
The majority of ongoing R&D activities being performed at Victoria University in collaboration with the
Company, including the construction, testing and operations of state-of-the-art aMES® and iBC® pilot
plant, is being partly funded by previously awarded grant funding.
The Company acknowledges the financial support of the Australian Government.
R&D Rebate
As a result of research and development activities performed and/or funded by the Company during
FY21, the Company anticipates receiving an Australian Government research and development tax
incentive (R&DTI) payment in the order of $0.24 million for eligible activities, in April 2022. The
Company continued to fund eligible activities during the reporting period, and expects to receive an
additional R&DTI payment for these activities, as part of an application covering FY22, at a later date.
Cash on Hand
As at 30 December 2021, the company held $4.9 million in cash reserves.
It should be noted that the reported cash balance excludes undrawn grant funds and the anticipated
R&DTI payment.
COVID-19 Impacts
The Company has continued to experience a range of disruptions during the quarter, including delays
in the transportation of goods and restrictions impacting the movement of staff to support various project
and business development related activities. The Melbourne based operations of the Company have
been particularly impacted, resulting in limited access to both the PPS facility, as well as research and
development facilities at Victoria University, where the majority of pilot studies are ordinarily performed
by the Company.
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
7
Investor Relations
Following the 2021 Annual General Meeting held on 16 December 2021, group managing director &
CEO, Bahay Ozcakmak, delivered a corporate presentation, highlighting recent achievements and an
outlook on near-term activities.
Change of Address
On 23 December 2021, Parkway advised that its registered office and principal place of business had
been changed to, the existing PPS-Melbourne operations address:
Warehouse 5
45 Bunnett Street
Sunshine North, VIC, 3020
Other Items
During the quarter, no exploration and evaluation related expenditures were incurred in relation to the
Karinga Lakes Potash Project due to the Native Title Objection related challenges outlined above.
During the same period, $0.60 million was incurred in relation to staff costs, $0.36 million in
administration and corporate costs, and $0.89 million for cost of goods sold and additional inventory.
As the Company entered into additional commercial arrangements, the net inventory available for sale
during the quarter increased further to approximately $1.50 million.
Additional details are provided in the attached Appendix 5B.
Payments to Related Parties
As outlined in the attached Appendix 5B (section 6.1), during the quarter approximately $0.12 million in
payments were made to related parties and their associates for director salaries, consultancy fees,
superannuation, and other related costs.
Tenement Interests
As at 31 December 2021 the Company held an interest in the following Mineral Exploration Licences
(ELs) held through the KLPP-JV:
Australian Projects – Karinga Lakes Potash Project
Tenement ID
EL32249
EL32250
EL32251
Location
Karinga Lakes
Karinga Lakes
Karinga Lakes
State
NT
NT
NT
Interest
15%
15%
15%
Activities Subsequent to Reporting Period
Integrated Management System
Based on an independent audit and site evaluation performed during January 2022, the Company
anticipates achieving certification for all the relevant standards, in the near term.
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
8
Wastewater Treatment Plant Contract
In January 2022, the Company was awarded a contract to perform an early-stage preliminary
engineering study to assist a government entity assess options for treating a problematic wastewater
source through potential onsite treatment.
The Company has recently presented an additional proposal for a similar application and is hopeful it
will be awarded a similar contract for an early-stage study, which may advance to a more in-depth and
commercially significant opportunity at a later date.
Innovative Membrane-Based Technology Pilot Plant
Subsequent to the reporting period, the Company took delivery of a small, packaged pilot plant
incorporating the innovative membrane-based technology described in the Parkway Process
Technologies – Third-Party Technologies section of this report.
This innovative membrane-based technology provides Parkway with a highly effective and selective
pre-concentration technology, which enables more dilute feedstocks including brine and/or wastewater
to be concentrated, before treatment with Parkway’s aMES® process technology platform.
The imported pilot plant now owned by Parkway, will enable Parkway to rapidly screen projects and
efficiently demonstrate the advantages of the technology to both existing and new partners and clients.
Completion of PhD Research Project
In order to support the ongoing development of proprietary intellectual property, since 2018, the
Company has been sponsoring innovative research being performed at Victoria University by a full-time
PhD student. The research topics involved the investigation and evaluation of mechanisms for fractional
recovery of minerals from wastewaters, with the findings presenting potentially significant commercial
opportunities. The PhD student has recently completed his thesis, which is currently undergoing several
internal reviews, before commencing external examiner reviews in coming months.
Given the research topics in the thesis directly relate to key processes within the aMES® technology
portfolio, the findings and thesis remain commercial in confidence, and will be embargoed for a period
of no less than 5 years.
The PhD student was co-supervised by senior Victoria University researchers, as well as Parkway
group managing director & CEO, who is also an Adjunct Associate Professor within the Institute of
Sustainable Industries & Liveable Cities, located at the Werribee campus of Victoria University.
The PhD research project was conducted through an Australian Research Council (ARC) research hub,
for which the Company acknowledges the financial support of the Australian Government.
On behalf of Parkway Corporate Limited.
Bahay Ozcakmak
Group Managing Director & CEO
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
9
The attached Appendix 5B has been authorised for release by Bahay Ozcakmak (Group MD &
CEO) and Robert Van der Laan (Group CFO).
ADDITIONAL INFORMATION
For further information or investor enquiries, please contact:
Bahay Ozcakmak
Alexander Cook
General Enquiries
Group MD & CEO
General Counsel
1300 7275929
solutions@pwnps.com
ir@pwnps.com
1300 PARKWAY
www.parkway-corp.com
DECEMBER 2021
|
QUARTERLY REPORT
|
10
FORWARD-LOOKING STATEMENTS
This announcement may contain certain “forward-looking statements”. The words “continue”, “expect”,
“forecast”, “potential” and other similar expressions are intended to identify “forward-looking
statements”. Indications of (and any guidance on) future earnings, financial position, capex
requirements and performance are also “forward-looking statements”, as are statements regarding
internal management estimates and assessments of market outlook.
Where Parkway expresses or implies an expectation or belief as to future events or results, such
expectation or belief is expressed in good faith and believed to have a reasonable basis. However,
“forward-looking statements” are not guarantees of future performance and involve known and unknown
risks, uncertainties and other factors, many of which are beyond the control of Parkway, its officers,
employees, agents and advisors, that may cause actual results to differ materially from those expressed
or implied in such statements. There can be no assurance that actual outcomes will not differ materially
from these statements. There are usually differences between forecast and actual results, because
events and actual circumstances frequently do not occur as forecast and their differences may be
material.
Parkway does not undertake any obligation to publicly release any revisions to any "forward-looking
statements" to reflect events or circumstances after the date of this announcement, or to reflect the
occurrence of unanticipated events, except as may be required under the applicable securities laws.
ABOUT PARKWAY CORPORATE LIMITED
Parkway Corporate Limited is an Australian cleantech company focused on developing and
implementing, industrial-scale innovative water treatment solutions. Parkway is listed on the
Australian Securities Exchange (ASX: PWN) and is emerging as an innovative player in water related
sustainability solutions. With significant inhouse technical expertise and established partnerships,
Parkway is well-placed to deliver the next generation of
Share your feedback
Discover